ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg
If approved, neffy 1 mg will be the first and only needle-free epinephrine treatment available for younger school-aged children The ...
Read moreIf approved, neffy 1 mg will be the first and only needle-free epinephrine treatment available for younger school-aged children The ...
Read moreSHANGHAI, China, April 07, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a ...
Read more— Oral presentation at the European Lung Cancer Congress 2024 of Phase IIIb data demonstrating median PFS of 13.7 months and ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.